Compare Canopy Growth Corp (CGC) vs Lennar Corporation (LEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Lennar Corporation — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while Lennar Corporation trades at $83.75 (market cap $20.12B). The key difference: Lennar Corporation is far larger — about 50.5× Canopy Growth Corp's market cap, and Lennar Corporation pays a 2.39% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | LEN | |
|---|---|---|
Market Cap | $398.46M | $20.12B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.92 | $142.40 |
52-Week Low | $0.86 | $82.30 |
Enterprise Value | $337.90M | $24.00B |
Dividend Yield | — | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Lennar Corporation (LEN) trades at $82.84, down 1.7% on the day, with technical indicators showing bearish momentum despite oversold RSI conditions. The stock faces fundamental pressure from declining revenue and net income margins, which fell to 6.07% in 2025 from 13.7% in 2022. Recent earnings misses and housing affordability challenges create headwinds, though analyst consensus remains positive with a $84.38 price target.
LEN presents a value opportunity with attractive valuation multiples (P/E 12.98, P/B 0.92) but faces execution risks amid declining profitability. The housing market's sensitivity to mortgage rates and competitive pressures require careful monitoring. Upside potential exists if operational improvements and housing policy support materialize, making this suitable for patient investors comfortable with cyclical exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →
